| Literature DB >> 26901189 |
Diego Robledo1, Carlos Fernández2, Miguel Hermida3, Andrés Sciara4, José Antonio Álvarez-Dios5, Santiago Cabaleiro6, Rubén Caamaño7, Paulino Martínez8, Carmen Bouza9.
Abstract
Growth traits represent a main goal in aquaculture breeding programs and may be related to adaptive variation in wild fisheries. Integrating quantitative trait loci (QTL) mapping and next generation sequencing can greatly help to identify variation in candidate genes, which can result in marker-assisted selection and better genetic structure information. Turbot is a commercially important flatfish in Europe and China, with available genomic information on QTLs and genome mapping. Muscle and liver RNA-seq from 18 individuals was carried out to obtain gene sequences and markers functionally related to growth, resulting in a total of 20,447 genes and 85,344 single nucleotide polymorphisms (SNPs). Many growth-related genes and SNPs were identified and placed in the turbot genome and genetic map to explore their co-localization with growth-QTL markers. Forty-five SNPs on growth-related genes were selected based on QTL co-localization and relevant function for growth traits. Forty-three SNPs were technically feasible and validated in a wild Atlantic population, where 91% were polymorphic. The integration of functional and structural genomic resources in turbot provides a practical approach for QTL mining in this species. Validated SNPs represent a useful set of growth-related gene markers for future association, functional and population studies in this flatfish species.Entities:
Keywords: RNA-seq; SNP; Scophthalmus maximus; candidate genes; growth; integrative genomics; turbot
Mesh:
Year: 2016 PMID: 26901189 PMCID: PMC4783974 DOI: 10.3390/ijms17020243
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
RNA-seq and transcriptome assembly statistics.
| Statistic | Muscle | Liver | Total |
|---|---|---|---|
| Raw reads | 19,326,140 | 17,466,901 | 36,793,041 |
| Trimmed reads | 17,596,236 (91.0%) | 16,398,082 (93.9%) | 33,994,318 (92.4%) |
| Concordant aligned reads | 15,570,568 (88.5%) | 14,805,040 (90.3%) | 30,375,608 (89.4%) |
| Number of genes | 19,147 | 15,928 | 20,447 |
| Number of transcripts | 27,664 | 22,061 | 33,795 |
| Minimum transcript size | 62 | 78 | 62 |
| Maximum transcript size | 67,989 | 17,880 | 67,989 |
| Transcripts over 500 bp | 26,659 | 21,319 | 32,650 |
| Mean transcript length (bp) | 2594.66 | 2428.24 | 2819.60 |
| N50 | 3411 | 3154 | 3691 |
| N90 | 1381 | 1293 | 1531 |
Concordant aligned reads are pairs of reads which were assembled at the same genomic location and the percentage shown is calculated to the trimmed reads.
Figure 1Single nucleotide polymorphisms (SNPs) detected in muscle and liver turbot RNA-seq. SNPs found by RNA-seq and aligned with turbot genomic sequences are separated according to their type.
Figure 2Predictive genome position of growth-related genes in the turbot genetic map. Estimated gene map positions are shown in red, underlining the 45 selected genes for SNP detection. (*) Map positions inferred by comparative mapping against model fish [26]. Reported growth-related markers [29,30,32] are shown in blue, either associated with growth traits (qBW, body weight; qL, length; qK, Fulton factor) or located within the confidence interval (CI) of growth QTLs. (†) Outlier markers proposed to be under selection in turbot [32].
Growth-related expressed genes selected for SNP screening in turbot.
| Gene 1 | Annotation | Organ 2 | LG 3 | QTL Marker 4 | Distance 5 (kbp) | QTL Information 6 (VPE) † |
|---|---|---|---|---|---|---|
|
| Acyl-CoA synthetase 3 | M&L | 16 | SmaUSC-E11 | 909 | BW-QTL (13%) |
|
| Actin, alpha cardiac muscle 1 | M | 3 | Sma-USC144 | 1995 | K-QTL (12%) |
|
| Akirin2 | M&L | 23 | nd | nd | L-QTL interval |
|
| Ser/Thr-protein kinase | M&L | 15 | Sma-USC211 | 1621 | BW, L-QTL (13%) |
|
| Calcium transporting ATPase1 | M | 21 | Sma-USC234 | 4364 | K-QTL interval |
|
| Choline phosphotransferase 1 | M&L | 16 * | nd | nd | BW-QTL (13%) |
|
| Alpha-enolase | M&L | 10 | SmaUSC-E32 | 5651 | K-QTL interval |
|
| Fatty acyl CoA reductase 2 | M&L | 6 | Sma-USC264 | 823 | BW, L-QTL interval |
|
| F-box protein 32 | M&L | 2 | Sma-USC242 | 1924 | K-QTL interval |
|
| Fibrobalst growth factor 6b | M | 16 | SmaUSC-E11 | 34 | K-QTL (25%) |
|
| Forkhead box M1 | M&L | 16 | SmaUSC-E11 | 762 | BW-QTL (13%) |
|
| Forkhead Box O1b | M&L | 8 | Sma-USC194 | 1843 | L-QTL interval |
|
| Growth hormone receptor 2 | M&L | 14 | nd | nd | BW, L-QTL interval |
|
| Glu-oxaloacetic transaminase 1a | M&L | 2 | Sma-USC112 | 622 | BW, L-QTL interval |
|
| Insulin-like growth factor 1 | L | 16 | SmaUSC-E11 | 1453 | K-QTL (25%) |
|
| Insulin-like growth factor 2b | M&L | 6 | nd | nd | BW, L-QTL interval |
|
| Igf binding protein 2 | L | 20 | Sma-USC29 | 7275 | L-QTL (8%) |
|
| Igf binding protein 3 | M | 1 | Sma-USC15 | 413 | BW-QTL (14%) |
|
| Insulin Receptor | M&L | 5 | Sma-USC247 | 2321 | BW, L-QTL interval |
|
| Janus kinase 2a | M&L | 14 | Sma-USC82 | 152 | BW-QTL (11%) |
|
| Janus kinase 2b | M&L | 12 | SmaUSC-E14 | 2037 | L-QTL (13%) |
|
| Leptin receptor | M&L | 5 | Sma-USC65 | 488 | BW, L-QTL interval |
|
| Lumican | M&L | 16 | Sma-USC223 | 504 | BW-QTL (13%) |
|
| Myocite enhancer factor a | M&L | 6 | nd | nd | BW, L-QTL interval |
|
| Mir133b | M | 23 | Sma-USC273 | 5066 | BW, L-QTL (11%) |
|
| Myostatin 1 | M | 20 * | nd | nd | L-QTL interval |
|
| Ser/Thr-protein kinase mTOR | M&L | 10 | nd | nd | F-QTL interval |
|
| Myoblast determination protein | M | 1 | Sma-USC101 | 351 | BW-QTL (8%) |
|
| Myogenin | M | 11 | Sma-USC158 | 3209 | K-QTL (10%) |
|
| Phenylalanine hydroxylase | M&L | 16 | SmaUSC-E11 | 1511 | BW-QTL (13%) |
|
| Pyruvate kinase | M&L | 2 | Sma-USC168 | 443 | K-QTL interval |
|
| Pyruvate kinase a, muscle | M&L | 4 | Sma-USC7 | 2610 | K-QTL (10%) |
|
| Pleiotrpophin. | L | 16 | SmaUSC-E11 | 693 | BW-QTL (13%) |
|
| Parvalbumin 1 | M | 21 | Sma-USC234 | 1911 | K-QTL interval |
|
| Mothers- decapentaplegic 4 | M&L | 14 | Sma-USC63 | 589 | BW-QTL (11%) |
|
| SRY-box 5 | M&L | 16 | Sma-USC256 | 560 | BW, L-QTL (8%) |
|
| Translocon protein gamma | M&L | 15 * | nd | nd | BW, L-QTL interal |
|
| Activator of transcription 5 | M&L | 21 | Sma-USC41 | 125 | K-QTL (4%) |
|
| Transforming growth factor β1 | M&L | 15 | nd | nd | BW-QTL interval |
|
| Transforming growth factor β2 | M&L | 2 * | nd | nd | BW, L-QTL inteval |
|
| Tgf β1 receptor | M&L | 17 | Sma-USC55 | 1569 | L-QTL (9%) |
|
| Tgf β2 receptor | M&L | 22 | nd | nd | Gene function † |
|
| Tgf β3 receptor | M&L | 5 | ScmM1 | 265 | BW, L-QTL (11%) |
|
| Troponin C, skeletal muscle | M | 10 * | nd | nd | K-QTL interval |
|
| Ubiquitin specific peptidase | M&L | 16 | SmaUSC-E11 | 84 | BW-QTL (13%) |
1 Gene symbol (Table S1, Supplementary Materials); 2 Organ expression: muscle (M) and/or liver (L); 3 Predicted Linkage Group (LG) containing the gene-specific scaffold (Table S1, Supplementary Materials) obtained either from anchor markers of the genetic map into the turbot genome or by comparative mapping against model fish (*); 4 Closest growth QTL marker within scaffold, if applicable (nd: Gene and QTL maker/s are not in the same scaffold); 5 Physical distance between genes and QTL markers; 6 Selection criteria: Gene function and/or distance to growth QTL (BW: Body weight, L: Length, K: Fulton’s factor [29,30]), either within QTL intervals or close to associated markers; VPE (%): Phenotypic variance explained by associated markers to growth traits, when applicable; † Outlier marker proposed to be under selection in turbot [32].
SNP markers for growth-related genes in turbot.
| SNP | Variant | Genomic Position 1 | Gene Region 2 | MAF 3 | He 5 | Fis 6 | |
|---|---|---|---|---|---|---|---|
|
| T/C | Sm_46: 2,118,151 | Exon syn | T = 0.368 | 1 | 0.471 | −0.06 |
|
| C/G | Sm_26: 4,028,782 | 3’ UTR | G = 0.324 | 0.7061 | 0.445 | 0.074 |
|
| C/T | Sm_31: 2,270,529 | 3’ UTR | T = 0.118 | 1 | 0.21 | −0.119 |
|
| A/T | Sm_11: 7,019,041 | 3’ UTR | A = 0.485 | 1 | 0.507 | 0.014 |
|
| G/A | Sm_183: 505,467 | Exon syn | T = 0.338 | 0.2538 | 0.453 | −0.234 |
|
| C/G | Sm_4: 2,026,813 | 5’ UTR | C = 0.25 | 1 | 0.381 | −0.005 |
|
| G/A | Sm_100: 790,917 | Exon syn | A = 0.088 | 1 | 0.163 | −0.082 |
|
| G/A | Sm_49: 505,467 | Exon R-Q | G = 1 | - | - | - |
|
| C/G | Sm_49: 1,237,830 | 5’ UTR | C = 0.344 | 0.1129 | 0.461 | 0.322 |
|
| C/G | Sm_14: 4,371,288 | Exon A-G | C = 0.353 | 1 | 0.463 | −0.015 |
|
| G/A | Sm_67: 9082 | Exon syn | G = 1 | - | - | - |
|
| C/A | Sm_35: 2,520,843 | 3’ UTR | C = 1 | - | - | - |
|
| G/T | Sm_49: 1,922,714 | Intron | T = 0.029 | 1 | 0.058 | −0.015 |
|
| G/A | Sm_15: 9,070,308 | 3’ UTR | A = 0.265 | 1 | 0.395 | −0.043 |
|
| A/G | Sm_2: 14,079,242 | 3’ UTR | G = 0.324 | 0.7061 | 0.445 | 0.074 |
|
| C/A | Sm_1: 12,956,648 | 3’ UTR | A = 0.103 | 1 | 0.187 | −0.1 |
|
| G/A | Sm_5: 4,670,818 | Exon syn | A = 0.132 | 1 | 0.233 | −0.138 |
|
| C/G | Sm_38: 2,890,626 | Intron | G = 0.441 | 0.7412 | 0.501 | 0.06 |
|
| A/T | Sm_18: 4,376,249 | 3’ UTR | A = 0.044 | 1 | 0.086 | −0.031 |
|
| A/G | Sm_5: 10,530,481 | Exon V-A | A = G = 0.5 | 0.7387 | 0.508 | 0.074 |
|
| T/C | Sm_36: 3,958,348 | 5’ UTR | C = 0.029 | 1 | 0.058 | −0.015 |
|
| C/G | Sm_15: 4,752,470 | 3’ UTR | G = 0.044 | 1 | 0.086 | −0.031 |
|
| C/A | Sm_47: 179,652 | 5’ UTR | A = 0.059 | 1 | 0.112 | −0.048 |
|
| A/T | Sm_275: 53,874 | 3’ UTR | A = 0.176 | 0.249 | 0.296 | 0.205 |
|
| C/A | Sm_21: 2,840,205 | Exon syn | A = 0.103 | 1 | 0.187 | −0.1 |
|
| G/T | Sm_84: 1,867,326 | Exon syn | G = 1 | - | - | - |
|
| A/T | Sm_9: 6,475,591 | 3’ UTR | T = 0.059 | 1 | 0.112 | −0.048 |
|
| G/C | Sm_49: 1,912,258 | 5’ UTR | C = 0.162 | 1 | 0.275 | 0.039 |
|
| C/T | Sm_6: 7,978,133 | 3’ UTR | C = 0.029 | 1 | 0.058 | −0.015 |
|
| A/C | Sm_32: 2,688,948 | Intron | A = 0.439 | 0.7262 | 0.501 | 0.093 |
|
| T/G | Sm_49: 1,163,341 | 3’ UTR | T = 0.25 | 0.0814 | 0.379 | −0.32 |
|
| C/T | Sm_11: 4,556,367 | 5’ UTR | T = 0.044 | 1 | 0.086 | −0.031 |
|
| C/T | Sm_38: 1,262,602 | 5’ UTR | T = 0.074 | 1 | 0.138 | −0.065 |
|
| C/T | Sm_40: 1,284,941 | Exon syn | C = 0.426 | 0.5019 | 0.496 | −0.128 |
|
| C/T | Sm_55: 538,312 | 3’ UTR | T = 0.176 | 1 | 0.295 | 0.003 |
|
| G/C | Sm_85: 414,378 | 3’ UTR | C = 0.309 | 0.686 | 0.434 | 0.119 |
|
| A/C | Sm_28: 3,438,353 | 5’ UTR | C = 0.426 | 1 | 0.496 | −0.007 |
|
| A/C | Sm_58: 12,144 | 3’ UTR | C = 0.132 | 1 | 0.233 | −0.138 |
|
| C/T | Sm_3: 2,957,935 | 3’ UTR | T = 0.029 | 1 | 0.058 | −0.015 |
|
| T/A | Sm_10: 2,181,357 | 3’ UTR | T = 0.235 | 0.6469 | 0.365 | −0.13 |
|
| T/C | Sm_34: 1,743,526 | Intron | C = 0.338 | 0.7061 | 0.454 | −0.102 |
|
| T/C | Sm_174: 11,856 | Exon syn | T = 0.368 | 1 | 0.471 | −0.06 |
|
| G/A | Sm_49: 555,569 | Exon S-L | A = 0.191 | 0.3136 | 0.313 | −0.222 |
1 SNP genome position (scaffold code: Position in pb); 2 SNP genic position (within exons synonymous mutations (syn) or amino acid substitutions are indicated); 3 Minimum allele frequency; 4 p-value for Hardy-Weinberg equilibrium (HW) test; 5 Unbiased genetic diversity; 6 Deviation from HW expected heterozygosity (Fixation index, FIS).